NKHANI ZABWINO ZA CHUANGKUN BIOTECH KU Msika WAKUNJA KWA SHANGHAI CHUANGKUN BIOTECH TB/NTM NUCLEIC ACID DETECTION KIT(LYOPHILIZED) YAVOMEREZEKA NDI INDONESIA FDA!

Posachedwapa, Shanghai Chuangkun Biotechnology Co., Ltd. idalandira chiphaso chachiwiri cholembetsa ku Indonesia FDA cha TB/NTM Nucleic Acid kuzindikira zida (lyophilized), motsogozedwa ndi (12+3) mtundu wa HPV kuzindikira PCR kit mwezi wapitawo.amene ananena kuti mankhwala Chuangkun Biotech aloledwa ndi Indonesia FDA, kuwongolera mankhwala kudziletsa anayamba, komanso kupereka thandizo lamphamvu Chuangkun Zazazatekinoloje kupititsa patsogolo msika mayiko.

Malinga ndi lipoti la World Health Organisation's Global TB Report 2022, akuti anthu pafupifupi 10.6 miliyoni adwala TB mu 2021. Kuwonjezeka kwa 4.5% kunali kuposa chaka cha 2020. anthu omwe ali ndi kachilombo ka HIV).Pamalo, ambiri TB odwala 2021 anali WHO zigawo South-East Asia (45%), Africa (23%) ndi Western Pacific (18%), ndi magawo ang'onoang'ono Eastern Mediterranean (8.1%), Americas. (2.9%) ndi Europe (2.2%).Poganizira za Mliri wa COVID-19, kupewa ndi kuwongolera chifuwa chachikulu kumakhala kovutirapo pa Plan of Termination of TB ya WHO.

TB/NTM Nucleic Acid yodziwira zida kuchokera ku CHUANGKUN Biotech idapangidwa ndi njira ya lyophilization .Njirayi idzathetsa kuipa kwa nthawi yayitali ya mayendedwe a zida zodziwikiratu za PCR, komanso zimabweretsa kulondola kwabwino kwambiri komanso zotsatira zatsatanetsatane kwambiri kuposa momwe tingagwiritsire ntchito.

Shanghai Chuangkun Biotechnology Co., Ltd. idalandira chiphaso chachiwiri cholembetsa cha Indonesia FDA cha TB/NTM Nucleic Acid kuzindikira zida, chikuwonetsa kuzindikiridwa ndi Indonesia FDA.Chuangkun Biotech idzadzipereka kuti igwire nawo ntchito yopewera chifuwa chachikulu cha TB ndikuwongolera mwachangu.